Join us at these events to expand your knowledge about psoriasis.
November 8, 2019 3:30 pm – 5:30 pm
Program Chairs: Jonathan Barker, UK; Christopher Griffiths, UK Program faculty: Hervé Bachelez, France; Masamoto Murakami, Japan; Kazumitsu Sugiura, Japan
This program is sponsored in part by Boehringer-Ingelheim.
Thursday, February 28, 2019 2:00 pm – 5:00 pm
Program chair: Arnon D. Cohen, Israel Program faculty: Robert Bissonnette, Canada; Jennifer Murase, USA; Jashin Wu, USA
Thursday, April 4, 2019 1:00 pm - 5:00 pm
Friday, April 5, 2019 9:00 am - 5:00 pm
Program chairs: Mahira El Sayed, Egypt; Mohamed El-Komy, Egypt International faculty: Chris Griffiths, UK; Peter van de Kerkhof, the Netherlands
Thursday, April 25, 2019 9:30 pm – 11:30 am
Program chair: Peter van de Kerkhof, the Netherlands Program faculty: Errol Prens, the Netherlands; Marieke Seyger, the Netherlands; Fernando Valenzuela, Chile; Ron Vender, Canada
Thursday, May 2, 2019 12:00 - 5:00 pm
Friday, May 3, 2019 9:00 am - 5:00 pm
Program chairs: Claudia de la Cruz, Chile; Ricardo Romiti, Brazil International faculty: Alan Menter, USA ; Peter van de Kerkhof, the Netherlands Regional faculty: Matías Maskin, Argentina; Fernando Valenzuela, Chile
Friday, May 3, 2019 2:30 pm - 4:00 pm
Program chairs: Cristina Echeverría, Argentina & César Gonzalez, Colombia Program faculty: Paula Luna, Argentina & Enrique Rivas, Guatemala
SOCIETY FOR INVESTIGATIVE DERMATOLOGY ANNUAL MEETING | CHICAGO, ILLINOIS, US
Wednesday, May 8, 2019 9:00 am - 1:00 pm
Program chairs: April Armstrong, USA; Johann Gudjonsson, USA; Nehal Mehta, USA Program faculty: Hafid Ait-Oufella, France; Joel Gelfand, USA; Marlies Wakkee, the Netherlands
This program is supported in part by an educational grant from AbbVie.
Monday, June 10, 2019 1:30 pm – 4:30 pm
Program chair: Jonathan Barker, UK Program faculty: Hervé Bachelez, France; Lars Iversen, Denmark; Kelly Cordoro, USA; Omid Zagari, Iran
Wednesday, September 18, 2019 2:00 pm – 6:00 pm
Program chairs: Michel Gilliet, Switzerland; Johann Gudjonsson, USA; Jörg Prinz, Germany Program faculty: Hervé Bachelez, France; Francesca Capon, UK; Chyung-Ru Wang, USA; Poster Presentations: Ian Catlett, USA; Athanasios Niaouris, UK; Lorenzo Pasquali, Sweden; Ashley Rider, UK; Enikö Pivarcsi Sonkoly, Sweden; Christian Thoma, Germany
Wednesday, October 9, 2019 9:00 am - 12:00 pm
Program chairs: Catherine Smith, UK; Bruce Strober, USA Program faculty: Lone Skov, Denmark; Robert Strohal, Austria; Tiago Torres, Portugal
This program is sponsored in part by Samsung Bioepis and Biogen.
congress coverage EADV 2019 Read the psoriasis highlights from the EADV 2019 congress learn more
now available COVID-19 Psoriasis Resource Center Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve explore now
Information from around the world on psoriasis and coronavirus to assist dermatologists and the patients they serve
Latest news Commentary: The risk of respiratory tract infections and symptoms in psoriasis patients treated with IL-17-pathway inhibiting biologicsMay 28, 2020Searching for signals of increased risk of infection in specific subgroups is vitally important, especially when confronted with a severe threat to health, like the worldwide spread of the SARS-CoV-2 virus. Stories from the Field: COVID-19 and Psoriatic ArthritisMay 27, 2020US-based rheumatologist and IPC Councilor Arthur Kavanaugh, MD, discusses his plans to continue offering telemedicine appointments to patients after the pandemic. "Telemedicine is a new skill set that [we] providers need to learn," says Dr. Kavanaugh in this week's Stories from the Field video. Translations NOW AVAILABLE: January 2020 Psoriasis Review NewsletterMay 26, 2020 Stories from the Field: Impact of COVID-19 restrictions on psoriasis patients in EgyptMay 20, 2020Due to COVID-19 restrictions, patients in Egypt with severe psoriasis are not getting timely access to biologic treatment. IPC Board Member Mahira Hamdy El Sayed, MSc, MD, discusses the potential fallout for Egyptians with psoriasis, post-COVID-19. More News